Gender-Specific Response to Interstitial Angiotensin II in Human White Adipose Tissue

Abstract

Angiotensin II is synthesized locally in various tissues. However, the role of interstitial angiotensin II in the regulation of regional metabolism and tissue perfusion has not as yet been clearly defined . We characterized the effect of interstially applied angiotensin II in abdominal subcutaneous adipose tissue of young, normal-weight, healthy men (n = 8) and women (n = 6) using the microdialysis technique. Adipose tissue was perfused with 0.01, 0.1, and 1 µM angiotensin II. Dialysate concentrations of ethanol, glycerol, glucose, and lactate were measured to assess changes in blood flow (ethanol dilution technique), lipolysis, and glycolysis, respectively. Baseline ethanol ratio and dialysate lactate were both significantly higher, whereas dialysate glucose was significantly lower in men vs. women. In men, ethanol ratio and dialysate glucose, lactate and glycerol did not change significantly during perfusion with angiotensin II. In women, however, angiotensin II induced a significant increase in ethanol ratio and dialysate lactate and a decrease in dialysate glucose close to values found for men and this response was almost maximal at the lowest angiotensin II concentration used. Dialysate glycerol did not change significantly. We conclude that baseline blood flow and glucose supply and metabolism is significantly higher in women than in men. In men, interstitial Ang II has only a minimal effect on adipose tissue blood flow and metabolism. In women, however, a high physiological concentration of interstitial angiotensin II can reduce blood flow down to values found in men. This is associated with an impaired glucose supply and metabolism. Additionally, Ang II inhibits lipolysis.

Glucose - Glycerol - Lactate - Pyruvate - Microcirculation - Microdialysis

References

• 1 Timmermans P BMWM, Wong P C, Chiu A T, Herblin W F, Benfield P, Carini D J, Lee R J, Wexler R R, Saye J AM, Smith R D. Angiotensin II receptors and angiotensin II receptor antagonists.  Pharmacol Rev. 1993;  45 205-251
• 2 Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.  Pharmacol Rev. 2000;  52 11-34
• 3 Berry C, Touyz R, Dominiczak F, Webb R C, Johns D G. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide.  Am J Physiol. 2001;  281 H2337-H2365
• 4 Brunner H R. Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease.  Am J Cardiol. 2001;  87 (8A) 3C-9C
• 5 Campbell D J. Circulating and tissue angiotensin systems.  J Clin Invest. 1987;  79 1-6
• 6 Engeli S, Negrel R, Sharma A M. Physiology and pathophysiology of the adipose tissue renin-angiotensin system.  Hypertension. 2000;  35 1270-1277
• 7 Engeli S, Sharma A M. Role of adipose tissue for cardiovascular-renal regulation in health and disease.  Horm Metab Res. 2000;  32 515-520
• 8 Nishiyama A, Seth D M, Navar L G. Renal interstitial fluid concentrations of angiotensin I and II in anesthetized rats.  Hypertension. 2002;  39 129-134
• 9 Boschmann M, Ringel J, Klaus S, Sharma A M. Metabolic and hemodynamic response of adipose tissue to angiotensin II.  Obes Res. 2001;  9 486-491
• 10 Jordan J, Tank J, Christensen N J, Franke G, Stoffels M, Luft F C, Boschmann M. Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism.  J Clin Endocrinol Metab. 2001;  86 2803-2810
• 11 Boschmann M, Krupp G, Luft F C, Klaus S, Jordan J. In vivo response on alpha-1 adrenoreceptor stimulation in human white adipose tissue.  Obes Res. 2002;  10 555-558
• 12 Boschmann M, Rosenbaum M, Leibel R L, Segal K R. Metabolic and hemodynamic responses to exercise in subcutaneous adipose tissue and skeletal muscle.  Int J Sports Med. 2002;  23 537-543
• 13 Lafontan M, Arner P. Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue.  Trends Pharmacol Sci. 1996;  17 309-313
• 14 Lönnroth P. Microdialysis in adipose tissue and skeletal muscle.  Horm Metab Res. 1997;  29 344-346
• 15 Bernt E, Gutmann I. Ethanol determination with alcohol dehydrogenase and NAD. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Weinheim; Verlag Chemie 1974: 1499-1505
• 16 Fellander G, Linde B, Bolinder L. Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans.  Int J Obes. 1996;  20 220-226
• 17 Arner P, Liljeqvist L, Östman J. Metabolism of mono- and diacyl-glycerols in subcutaneous adipose tissue of obese and normal weight subjects.  Acta Med Scand. 1976;  200 187-194
• 18 Rosdahl H, Ungerstedt U, Jorfeldt L, Henriksson J. Interstitial glucose and lactate balance in human skeletal muscle and adipose tissue studied by microdialysis.  J Physiol. 1993;  471 637-657
• 19 Stahle L, Segersvard S, Ungerstedt U. A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis.  J Pharmacol Methods. 1991;  25 41-52
• 20 Di Girolamo M, Skinner N S, Hanley H G, Sachs R G. Relationship of adipose tissue blood flow to fat cell size and number.  Am J Physiol. 1971;  220 932-937
• 21 Virtanen K A, Lönnroth P, Parkkola R, Peltoniemi P, Asola M, Viljanen T, Tolvanen T, Knuuti J, Rönnemaa T, Huupponen R, Nuutila P. Glucose uptake and perfusion in subcuatneous and visceral adipose tissue during insulin stimulation in non-obese and obese humans.  J Clin Endocrinol Metab. 2002;  87 3902-3910
• 22 Hellström L, Blaak E, Hagström-Toft E. Gender differences in adrenergic regulation of lipid mobilization during exercise.  Int J Sports Med. 1996;  17 439-447
• 23 Lam H C, Lee J K, Chiang H AT, Chuang M J, Wang M C. Is captopril-induced improvement of insulin sensitivity mediated via endothelin?.  J Cardiovasc Pharmacol. 1998;  31 (Suppl. 1) 496-500
• 24 Caldiz C I, de Cingolani G E. Insulin resistance in adipocytes from spontaneously hypertensive rats: effect of long-term treatment with enalapril and losartan.  Metabolism. 1999;  48 1041-1046
• 25 Darimont C, Vassaux G, Gaillard D, Ailhaud G, Negrel R. In situ microdialysis of prostaglandins in adipose tissue: stimulation of prostacyclin release by angiotensin II.  Int J Obes Relat Metab Disord. 199 4;  18 783-788
• 26 Lafontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function.  J Lipid Res. 1993;  34 1057-1091
• 27 Jones B H, Standridge M K, Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells.  Endocrinology. 1997;  138 1512-1519
• 28 Nussberger J, Brunner D B, Waeber B, Brunner H R. Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma.  Hypertension. 1986;  8 476-482
• 29 Campbell D J, Kladis A. Simultaneous radioimmunoassay of six angiotensin peptides in arterial and venous plasma of man.  J Hypertens. 1990;  8 165-172